[HTML][HTML] Therapeutic effects of photobiomodulation therapy on multiple sclerosis by regulating the inflammatory process and controlling immune cell activity: a novel …

S Vafaei-Nezhad, S Niknazar… - Journal of Lasers in …, 2022 - ncbi.nlm.nih.gov
Introduction: Multiple sclerosis (MS) is one of the autoimmune and chronic diseases of the
central nervous system; this disease occurs more frequently in young people and women …

Systematic review of photobiomodulation for multiple sclerosis

V Oliveira de Andrade Filho, MOC Amarante… - Frontiers in …, 2024 - frontiersin.org
Background Multiple sclerosis (MS) is an inflammatory chronic autoimmune and
neurodegenerative disorder of the brain and spinal cord, resulting in loss of motor, sensorial …

[HTML][HTML] The role of low-level laser therapy in the treatment of multiple sclerosis: A review study

N Hossein-Khannazer, MK Arki… - Journal of Lasers in …, 2021 - ncbi.nlm.nih.gov
Introduction: Multiple sclerosis (MS) is an autoimmune disease. Inflammatory cells, cytokines
and chemokines play a major role in the pathogenesis of the disease. Low-level laser …

Current application and future directions of photobiomodulation in central nervous diseases

M Yang, Z Yang, P Wang, Z Sun - Neural Regeneration Research, 2021 - journals.lww.com
Photobiomodulation using light in the red or near-infrared region is an innovative treatment
strategy for a wide range of neurological and psychological conditions. Photobiomodulation …

Photobiomodulation for the treatment of neuroinflammation: A systematic review of controlled laboratory animal studies

FS Cardoso, F Salehpour, NC Coimbra… - Frontiers in …, 2022 - frontiersin.org
Background Neuroinflammation is a response that involves different cell lineages of the
central nervous system, such as neurons and glial cells. Among the non-pharmacological …

[HTML][HTML] Therapeutic potential of photobiomodulation in Alzheimer's disease: a systematic review

F dos Santos Cardoso, RÁBL Martins… - Journal of Lasers in …, 2020 - ncbi.nlm.nih.gov
Introduction: Alzheimer disease (AD) is characterized by the decline of cognitive functions
such as learning and memory. Scientific society has proposed some non-pharmacological …

The molecular mechanisms of action of photobiomodulation against neurodegenerative diseases: a systematic review

M Bathini, CR Raghushaker, KK Mahato - Cellular and Molecular …, 2022 - Springer
Neurodegenerative diseases might be slow but relentless, as we continue to fail in treating
or delaying their progression. Given the complexity in the pathogenesis of these diseases, a …

Effect of photobiomodulation treatment in the sublingual, radial artery region, and along the spinal column in individuals with multiple sclerosis: protocol for a …

T da Silva, FC da Silva, AO Gomes, AO Viana… - Medicine, 2018 - journals.lww.com
Background: Multiple sclerosis (MS) is an autoimmune disease, for which the forms of
treatment are medication and rehabilitation. However, in vitro and in vivo studies have …

Photobiomodulation therapy (PBMT) regulates the production of IL-10 and IFN-Ɣ by peripheral blood mononuclear cells (PBMC) and CD4+ T cells isolated from …

M Tolentino, CC Cho, JA Lyons - The Journal of Immunology, 2019 - journals.aai.org
Multiple sclerosis (MS) is a CD4+ Th1/Th17 mediated autoimmune disease characterized by
myelin destruction, neurodegeneration and mitochondrial dysfunction. Current therapies …

Photobiomodulation for Neurodegenerative Diseases: A Scoping Review

Q Shen, H Guo, Y Yan - International Journal of Molecular Sciences, 2024 - mdpi.com
Neurodegenerative diseases involve the progressive dysfunction and loss of neurons in the
central nervous system and thus present a significant challenge due to the absence of …